Thymosin beta-4

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Thymosin beta-4
Accession Number
DB12003
Description

Thymosin Beta 4 has been investigated for the treatment of STEMI, Dry Eye, Diabetes, Pressure Ulcers, and Dry Eye Syndrome, among others.

Type
Biotech
Groups
Investigational
Biologic Classification
Protein Based Therapies
Other protein based therapies
Purchasing individual compounds or compound libraries for your research?
Learn More
Protein Chemical Formula
Not Available
Protein Average Weight
Not Available
Sequences
Not Available
Synonyms
  • Thymosin beta 4

Pharmacology

Indication
Not Available
Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
Not Available
Kingdom
Organic Compounds
Super Class
Organic Acids
Class
Carboxylic Acids and Derivatives
Sub Class
Amino Acids, Peptides, and Analogues
Direct Parent
Peptides
Alternative Parents
Not Available
Substituents
Not Available
Molecular Framework
Not Available
External Descriptors
Not Available

Chemical Identifiers

UNII
549LM7U24W
CAS number
77642-24-1

References

General References
Not Available
PubChem Substance
347911268
Wikipedia
Thymosin_beta-4

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
3CompletedTreatmentDry Eye Syndrome (DES)1
3RecruitingTreatmentDry Eye Syndromes / Dry Eyes1
2CompletedTreatmentDry Eye Syndrome (DES) / Dry Eyes1
2CompletedTreatmentDry Eyes / Graft Versus Host Disease (GVHD) / Sjögren's Syndrome1
2CompletedTreatmentPressure Ulcers1
2CompletedTreatmentVenous Stasis Ulcers (VSU)1
2SuspendedTreatmentAcute Myocardial Infarction (AMI) / ST Elevation Myocardial Infarction / ST Elevation Myocardial Infarction (STEMI)1
2TerminatedTreatmentDiabetes1
2TerminatedTreatmentEpidermolysis Bullosa1
2, 3CompletedTreatmentDry Eye Syndrome (DES)1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created on October 20, 2016 15:10 / Updated on June 12, 2020 10:53

Cs molecular health 1